Literature DB >> 23043691

State-related alterations of gene expression in bipolar disorder: a systematic review.

Klaus Munkholm1, Maj Vinberg, Michael Berk, Lars Vedel Kessing.   

Abstract

OBJECTIVE: Alterations in gene expression in bipolar disorder have been found in numerous studies. It is unclear whether such alterations are related to specific mood states. As a biphasic disorder, mood state-related alterations in gene expression have the potential to point to markers of disease activity, and trait-related alterations might indicate vulnerability pathways. This review therefore evaluated the evidence for whether gene expression in bipolar disorder is state or trait related.
METHODS: A systematic review, using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline for reporting systematic reviews, based on comprehensive database searches for studies on gene expression in patients with bipolar disorder in specific mood states, was conducted. We searched Medline, Embase, PsycINFO, and The Cochrane Library, supplemented by manually searching reference lists from retrieved publications.
RESULTS: A total of 17 studies were included, comprising 565 patients and 418 control individuals. Six studies evaluated intraindividual alterations in gene expression across mood states. Two of five studies found evidence of intraindividual alterations in gene expression between a depressed state and a euthymic state. No studies evaluated intraindividual differences in gene expression between a manic state and a euthymic state, while only one case study evaluated differences between a manic state and a depressed state, finding altered expression in seven genes. No study investigated intraindividual variations in gene expression between a euthymic state and multiple states of various polarities (depressive, manic, hypomanic). Intraindividual alterations in expression of the same genes were not investigated across studies. Only one gene (the brain-derived neurotrophic factor gene; BDNF) was investigated across multiple studies, showing no alteration between bipolar disorder patients and control individuals.
CONCLUSIONS: There is evidence of some genes exhibiting state-related alterations in expression in bipolar disorder; however, this finding is limited by the lack of replication across studies. Further prospective studies are warranted, measuring gene expression in various affective phases, allowing for assessment of intraindividual differences.
© 2012 John Wiley and Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043691     DOI: 10.1111/bdi.12005

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  16 in total

Review 1.  Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach.

Authors:  Rodrigo Machado-Vieira; Marcio G Soeiro-De-Souza; Erica M Richards; Antonio L Teixeira; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-02       Impact factor: 4.132

2.  Explore the Features of Brain-Derived Neurotrophic Factor in Mood Disorders.

Authors:  Fan-Chi Yeh; Chung-Feng Kao; Po-Hsiu Kuo
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

3.  Gene expression profiles in relation to tension and dissociation in borderline personality disorder.

Authors:  Christian Schmahl; Lars Arvastson; Joseph A Tamm; Martin Bohus; Aicha Abdourahman; Irina Antonijevic
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

4.  Reduced mRNA expression of PTGDS in peripheral blood mononuclear cells of rapid-cycling bipolar disorder patients compared with healthy control subjects.

Authors:  Klaus Munkholm; Lone Peijs; Lars Vedel Kessing; Maj Vinberg
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-07       Impact factor: 5.176

5.  Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses.

Authors:  Hiroaki Hori; Daimei Sasayama; Toshiya Teraishi; Noriko Yamamoto; Seiji Nakamura; Miho Ota; Kotaro Hattori; Yoshiharu Kim; Teruhiko Higuchi; Hiroshi Kunugi
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379

6.  The Bipolar Illness Onset study: research protocol for the BIO cohort study.

Authors:  Lars Vedel Kessing; Klaus Munkholm; Maria Faurholt-Jepsen; Kamilla Woznica Miskowiak; Lars Bo Nielsen; Ruth Frikke-Schmidt; Claus Ekstrøm; Ole Winther; Bente Klarlund Pedersen; Henrik Enghusen Poulsen; Roger S McIntyre; Flavio Kapczinski; Wagner F Gattaz; Jakob Bardram; Mads Frost; Oscar Mayora; Gitte Moos Knudsen; Mary Phillips; Maj Vinberg
Journal:  BMJ Open       Date:  2017-06-23       Impact factor: 2.692

7.  A composite peripheral blood gene expression measure as a potential diagnostic biomarker in bipolar disorder.

Authors:  K Munkholm; L Peijs; M Vinberg; L V Kessing
Journal:  Transl Psychiatry       Date:  2015-08-04       Impact factor: 6.222

8.  Monitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man.

Authors:  Raoul Belzeaux; Jean-Michel Azorin; El Chérif Ibrahim
Journal:  BMC Psychiatry       Date:  2014-03-12       Impact factor: 3.630

Review 9.  Integrated neurobiology of bipolar disorder.

Authors:  Vladimir Maletic; Charles Raison
Journal:  Front Psychiatry       Date:  2014-08-25       Impact factor: 4.157

10.  Increased DNA and RNA damage by oxidation in patients with bipolar I disorder.

Authors:  A S Jacoby; M Vinberg; H E Poulsen; L V Kessing; K Munkholm
Journal:  Transl Psychiatry       Date:  2016-08-09       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.